Chappell et al. (2024) “Use of HSC targeted LNP to generate a mouse model of lethal α-Thalassemia and treatment via lentiviral gene therapy” Blood.
DOI: 10.1182/blood.2023023349
Read
about Chappell et al. (2024) “Use of HSC targeted LNP to generate a mouse model of lethal α-Thalassemia and treatment via lentiviral gene therapy” Blood.
Leonard et al. (2024) “Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA” Nature Communications.
DOI: 10.1038/s41467-024-52940-z
Read
about Leonard et al. (2024) “Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA” Nature Communications.
Cohen et al. (2024) “Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals” Cell.
DOI: 10.1016/j.cell.2024.07.052
Read
about Cohen et al. (2024) “Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals” Cell.
Alameh et al. (2024) “A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection” Science.
DOI: 10.1126/science.adn4955
Read
about Alameh et al. (2024) “A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection” Science.
Atochina-Vasserman et al. (2024) “Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection” NPJ Vaccines.
DOI: 10.1038/s41541-024-00976-z
Read
about Atochina-Vasserman et al. (2024) “Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection” NPJ Vaccines.
Kafle et al. (2024) “The roles of CD4+ T cell help, sex, and dose in the induction of protective CD8+ T cells against a lethal poxvirus by mRNA-LNP vaccines” Molecular Therapy Nucleic Acids.
DOI: 10.1016/j.omtn.2024.102279
Read
about Kafle et al. (2024) “The roles of CD4+ T cell help, sex, and dose in the induction of protective CD8+ T cells against a lethal poxvirus by mRNA-LNP vaccines” Molecular Therapy Nucleic Acids.
Kuzmin et al. (2024) “Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine” Nature Communications.
DOI: 10.1038/s41467-024-50774-3
Read
about Kuzmin et al. (2024) “Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine” Nature Communications.
Guenaga et al. (2024) “mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies” Frontiers in Immunology.
DOI: 10.3389/fimmu.2024.1426232
Read
about Guenaga et al. (2024) “mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies” Frontiers in Immunology.
England et al. (2024) “Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model” NPJ Vaccines.
DOI: 10.1038/s41541-024-00901-4
Read
about England et al. (2024) “Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model” NPJ Vaccines.
Smith et al. (2024) “Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice” Nature Communications.
DOI: 10.1038/s41467-024-49332-8
Read
about Smith et al. (2024) “Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice” Nature Communications.